LEBRIKIZUMAB-LBKZ

2280 reported adverse events

Drug classes: Interleukin-13 Antagonist [EPC]

These side effects are most commonly reported by patients taking LEBRIKIZUMAB-LBKZ:

# Side effect Count
0 PRURITUS 264
1 INJECTION SITE PAIN 260
2 DRUG INEFFECTIVE 241
3 RASH 178
4 CONJUNCTIVITIS 154
5 DERMATITIS ATOPIC 149
6 ECZEMA 135
7 ERYTHEMA 109
8 DRY SKIN 79
9 INCORRECT DOSE ADMINISTERED 72
See all common reactions for LEBRIKIZUMAB-LBKZ

LEBRIKIZUMAB-LBKZ is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EYELID DISCOLOURATION 2 0.0392
1 MALIGNANT MELANOMA STAGE 0 2 0.0096
2 CONJUNCTIVITIS 154 0.0083
3 CUTANEOUS T-CELL LYMPHOMA 10 0.0079
4 PERIORAL DERMATITIS 4 0.0063
5 INJECTION SITE EXFOLIATION 4 0.0060
6 ECZEMA EYELIDS 3 0.0054
7 KERATOCONUS 2 0.0053
8 ECZEMA HERPETICUM 2 0.0043
9 VITILIGO 7 0.0030
See all enriched reactions for LEBRIKIZUMAB-LBKZ